Steven Cohen's RXST Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 733,307 shares of RxSight, Inc. (RXST) worth $4.52 M, representing 0.01% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in RXST, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 1.08 M shares. Largest reduction occurred in Q1 2026, reducing 497,546 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's RxSight (RXST) Holding Value Over Time
Track share changes against reported price movement
Quarterly RxSight (RXST) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -497,546 | Reduce 40.42% | 733,307 | $6.16 |
| Q4 2025 | +1.08 M | Add 692.62% | 1.23 M | $10.42 |
| Q3 2025 | +155,290 | New Buy | 155,290 | $8.99 |
| Q2 2025 | -154,012 | Sold Out | 0 | $0.00 |
| Q1 2025 | -237,720 | Reduce 60.68% | 154,012 | $25.25 |
| Q4 2024 | -55,244 | Reduce 12.36% | 391,732 | $34.38 |
| Q3 2024 | +384,041 | Add 610.22% | 446,976 | $49.43 |
| Q2 2024 | +46,336 | Add 279.15% | 62,935 | $60.17 |
| Q1 2024 | -227,116 | Reduce 93.19% | 16,599 | $51.58 |
| Q4 2023 | -412,230 | Reduce 62.85% | 243,715 | $40.32 |
| Q3 2023 | +83,502 | Add 14.59% | 655,945 | $27.89 |
| Q2 2023 | +224,275 | Add 64.42% | 572,443 | $28.80 |
| Q1 2023 | +90,468 | Add 35.11% | 348,168 | $16.68 |
| Q4 2022 | +20,059 | Add 8.44% | 257,700 | $12.67 |
| Q3 2022 | +237,641 | New Buy | 237,641 | $12.00 |
| Q2 2022 | -17,500 | Sold Out | 0 | $0.00 |
| Q1 2022 | +17,500 | New Buy | 17,500 | $12.40 |
Steven Cohen's RxSight Investment FAQs
Steven Cohen first purchased RxSight, Inc. (RXST) in Q1 2022, acquiring 17,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held RxSight, Inc. (RXST) for 17 quarters since Q1 2022.
Steven Cohen's largest addition to RxSight, Inc. (RXST) was in Q4 2025, adding 1,230,853 shares worth $12.83 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 733,307 shares of RxSight, Inc. (RXST), valued at approximately $4.52 M.
As of the Q1 2026 filing, RxSight, Inc. (RXST) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in RxSight, Inc. (RXST) was 1,230,853 shares, as reported at the end of Q4 2025.